SCHEMBL11294960

SCHEMBL11294960

CC(C)(c1ccc(-c2ccccc2)cc1)N(c1ccc(C(=O)NO)cc1)C1CCNC1=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 9/20 0.41
▸ HDAC6 Q9UBN7 9/20 0.41
▸ HDAC1 Q13547 8/20 0.41
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HDAC3 O15379 3/20 0.38
▸ HDAC4 P56524 3/20 0.38
▸ HDAC7 Q8WUI4 3/20 0.38
▸ HDAC2 Q92769 3/20 0.38
▸ HDAC10 Q969S8 3/20 0.38
▸ HDAC11 Q96DB2 3/20 0.38
▸ HDAC9 Q9UKV0 3/20 0.38
▸ HDAC5 Q9UQL6 3/20 0.38
▸ LIPG Q9Y5X9 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301460 0.95 HDAC8 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC4
SCHEMBL11294962 0.77 HDAC6 (0.40) HDAC8HDAC6HDAC1MEN1NPC1
SCHEMBL11296174 0.77 HDAC8 (0.44) HDAC8HDAC6HDAC1MEN1NPC1
SCHEMBL11299511 0.74 HDAC8 (0.41) HDAC8HDAC6HDAC1HDAC3HDAC4
SCHEMBL11297375 0.74 HDAC8 (0.44) HDAC8HDAC6HDAC1MEN1NPC1
SCHEMBL11300775 0.73 HDAC1 (0.50) HDAC8HDAC6HDAC1HDAC3HDAC4
SCHEMBL11297519 0.72 HDAC6 (0.43) HDAC8HDAC6HDAC1NPC1RAB9A
SCHEMBL11301466 0.72 HDAC1 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC4
SCHEMBL11301463 0.72 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC3HDAC4
SCHEMBL11299163 0.70 HDAC6 (0.40) HDAC8HDAC6HDAC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback